HC Wainwright & Co. Reiterates Buy on ZyVersa Therapeutics, Maintains $12 Price Target

Moomoo 24/7 ·  Mar 26 06:16

HC Wainwright & Co. analyst Ed Arce reiterates ZyVersa Therapeutics (NASDAQ:ZVSA) with a Buy and maintains $12 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment